This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2010 Jan;59(1):9-10.

doi: 10.1136/gut.2009.192666.

Screening for colorectal cancer: flexible sigmoidoscopy and faecal occult blood immunochemical testing. Which test is superior?

Guido Castiglione¹

Affiliations

Affiliation

¹ ISPO-Cancer Prevention and Research Institute, Department of Screening - Digestive Endoscopy, Villa delle Rose, Via Cosimo il Vecchio 2, 50139 Florence, Italy. g.castiglione@ispo.toscana.it

PMID: 20007956
DOI: 10.1136/gut.2009.192666

Comment

Screening for colorectal cancer: flexible sigmoidoscopy and faecal occult blood immunochemical testing. Which test is superior?

Guido Castiglione. Gut. 2010 Jan.

. 2010 Jan;59(1):9-10.

doi: 10.1136/gut.2009.192666.

Author

Guido Castiglione¹

Affiliation

¹ ISPO-Cancer Prevention and Research Institute, Department of Screening - Digestive Endoscopy, Villa delle Rose, Via Cosimo il Vecchio 2, 50139 Florence, Italy. g.castiglione@ispo.toscana.it

PMID: 20007956
DOI: 10.1136/gut.2009.192666

No abstract available

PubMed Disclaimer

Comment on

Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy.
Hol L, van Leerdam ME, van Ballegooijen M, van Vuuren AJ, van Dekken H, Reijerink JC, van der Togt AC, Habbema JD, Kuipers EJ. Hol L, et al. Gut. 2010 Jan;59(1):62-8. doi: 10.1136/gut.2009.177089. Gut. 2010. PMID: 19671542 Clinical Trial.

Similar articles

Testing for faecal calprotectin (PhiCal) in the Norwegian Colorectal Cancer Prevention trial on flexible sigmoidoscopy screening: comparison with an immunochemical test for occult blood (FlexSure OBT).
Hoff G, Grotmol T, Thiis-Evensen E, Bretthauer M, Gondal G, Vatn MH. Hoff G, et al. Gut. 2004 Sep;53(9):1329-33. doi: 10.1136/gut.2004.039032. Gut. 2004. PMID: 15306594 Free PMC article. Clinical Trial.
Randomized trial of the addition of flexible sigmoidoscopy to faecal occult blood testing for colorectal neoplasia population screening.
Berry DP, Clarke P, Hardcastle JD, Vellacott KD. Berry DP, et al. Br J Surg. 1997 Sep;84(9):1274-6. Br J Surg. 1997. PMID: 9313712 Clinical Trial.
Screening for rectal cancer.
St John DJ. St John DJ. Hepatogastroenterology. 2000 Mar-Apr;47(32):305-9. Hepatogastroenterology. 2000. PMID: 10791177 Review.
Colorectal cancer screening with the addition of flexible sigmoidoscopy to guaiac-based faecal occult blood testing: a French population-based controlled study (Wintzenheim trial).
Denis B, Gendre I, Aman F, Ribstein F, Maurin P, Perrin P. Denis B, et al. Eur J Cancer. 2009 Dec;45(18):3282-90. doi: 10.1016/j.ejca.2009.06.015. Epub 2009 Aug 6. Eur J Cancer. 2009. PMID: 19665368
Flexible sigmoidoscopy versus fecal occult blood testing for colorectal cancer screening in asymptomatic individuals.
Stern C. Stern C. Clin J Oncol Nurs. 2014 Aug;18(4):471-2. doi: 10.1188/14.CJON.471-472. Clin J Oncol Nurs. 2014. PMID: 25095304 Review.

See all similar articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- HighWire
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information